|
Emergency diagnosis of lung cancer: An international problem. |
|
|
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; MSD Oncology; Otsuka; Pierre Fabre; Roche Pharma AG |
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; Otsuka; Roche Pharma AG |
Travel, Accommodations, Expenses - Boehringer Ingelheim; Lilly; Otsuka; Roche Pharma AG |
|
|
Consulting or Advisory Role - Italfarmaco; Lilly; Otsuka |
Research Funding - Bristol-Myers Squibb |
|
|
No Relationships to Disclose |
|
|
Honoraria - Boehringer Ingelheim; Lilly; Roche Pharma AG |
Consulting or Advisory Role - Boehringer Ingelheim; Lilly; Pfizer; Roche Pharma AG |
Speakers' Bureau - Boehringer Ingelheim; Pfizer |
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Pfizer; Roche Pharma AG |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Lilly; MSD; Roche Pharma AG; Sanofi |
Travel, Accommodations, Expenses - Janssen; Novartis |
|
|
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; Novartis |
|
|
Honoraria - Boehringer Ingelheim; Lilly |
Travel, Accommodations, Expenses - Boehringer Ingelheim; Lilly; Roche Pharma AG |
|
|
No Relationships to Disclose |